English
norskExtended-spectrum β-lactamases and carbapenemases in clinical isolates of Enterobacteriaceae in Norway. Aspects of detection and epidemiology.
Permanent lenke
https://hdl.handle.net/10037/7599
Åpne
Thesis introduction (PDF)
Ståle Tofteland, Umaer Naseer, Jan Helge Lislevand, Arnfinn Sundsfjord, and Ørjan Samuelsen.: ‘A long-term low-frequent hospital outbreak of KPC-producing Klebsiella pneumoniae involving intergenus plasmid diffusion and a persisting environmental reservoir’. PLOS ONE, 2013, (8)3; e59015. Also available in PLOS ONE, 2013, (8)3; e59015 (PDF)
Dato
2015-04-16Type
Doctoral thesisDoktorgradsavhandling
Beskrivelse
Paper 1, 2 and 3 of this thesis are not available in Munin:
1. Tofteland S, Haldorsen B, Dahl KH, Simonsen GS, Steinbakk M, Walsh TR, Sundsfjord A; Norwegian ESBL Study Group.: ‘Effects of phenotype and genotype on methods for detection of extended-spectrum-beta-lactamase-producing clinical isolates of Escherichia coli and Klebsiella pneumoniae in Norway’. J.Clin.Microbiol. 2007; 45(1):199-205. Avalable in J.Clin.Microbiol. 2007; 45(1):199-205
2. Naseer U, Haldorsen B, Tofteland S, Hegstad K, Scheutz F, Simonsen GS, Sundsfjord A;Norwegian ESBL Study Group.: ‘Molecular characterization of CTX-M-15-producing clinical isolates of Escherichia coli reveals the spread of multidrug-resistant ST131 (O25:H4) and ST964 (O102:H6) strains in Norway’. APMIS. 2009;117(7):526-36. Available in APMIS. 2009;117(7):526-36
3. Tofteland S, Dahl KH, Aasnæs B, Sundsfjord A, Naseer U.: ' A nationwide study of mechanisms conferring reduced susceptibility to extended-spectrum cephalosporins in clinical Escherichia coli and Klebsiella spp. isolates'. Scand J Infect Dis. 2012;44(12):927-33. Available in Scand J Infect Dis. 2012;44 (12), 927-33
1. Tofteland S, Haldorsen B, Dahl KH, Simonsen GS, Steinbakk M, Walsh TR, Sundsfjord A; Norwegian ESBL Study Group.: ‘Effects of phenotype and genotype on methods for detection of extended-spectrum-beta-lactamase-producing clinical isolates of Escherichia coli and Klebsiella pneumoniae in Norway’. J.Clin.Microbiol. 2007; 45(1):199-205. Avalable in J.Clin.Microbiol. 2007; 45(1):199-205
2. Naseer U, Haldorsen B, Tofteland S, Hegstad K, Scheutz F, Simonsen GS, Sundsfjord A;Norwegian ESBL Study Group.: ‘Molecular characterization of CTX-M-15-producing clinical isolates of Escherichia coli reveals the spread of multidrug-resistant ST131 (O25:H4) and ST964 (O102:H6) strains in Norway’. APMIS. 2009;117(7):526-36. Available in APMIS. 2009;117(7):526-36
3. Tofteland S, Dahl KH, Aasnæs B, Sundsfjord A, Naseer U.: ' A nationwide study of mechanisms conferring reduced susceptibility to extended-spectrum cephalosporins in clinical Escherichia coli and Klebsiella spp. isolates'. Scand J Infect Dis. 2012;44(12):927-33. Available in Scand J Infect Dis. 2012;44 (12), 927-33
Forlag
UiT The Arctic University of NorwayUiT Norges arktiske universitet
Metadata
Vis full innførselSamlinger
Copyright 2015 The Author(s)
Følgende lisensfil er knyttet til denne innførselen:
Med mindre det står noe annet, er denne innførselens lisens beskrevet som Attribution-NonCommercial-ShareAlike 3.0 Unported (CC BY-NC-SA 3.0)